$25.61 Billion in Sales Expected for Express Scripts Holding Company (ESRX) This Quarter
Wall Street brokerages forecast that Express Scripts Holding Company (NASDAQ:ESRX) will report $25.61 billion in sales for the current quarter, Zacks reports. Ten analysts have issued estimates for Express Scripts Holding’s earnings, with the highest sales estimate coming in at $26.07 billion and the lowest estimate coming in at $25.18 billion. Express Scripts Holding posted sales of $25.41 billion during the same quarter last year, which would indicate a positive year-over-year growth rate of 0.8%. The company is expected to report its next earnings results after the market closes on Tuesday, October 24th.
On average, analysts expect that Express Scripts Holding will report full year sales of $25.61 billion for the current year, with estimates ranging from $99.87 billion to $102.31 billion. For the next fiscal year, analysts forecast that the company will post sales of $102.94 billion per share, with estimates ranging from $99.24 billion to $106.25 billion. Zacks Investment Research’s sales averages are an average based on a survey of sell-side analysts that cover Express Scripts Holding.
Express Scripts Holding (NASDAQ:ESRX) last issued its earnings results on Tuesday, July 25th. The company reported $1.73 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.02. Express Scripts Holding had a net margin of 3.50% and a return on equity of 25.58%. The company had revenue of $25.35 billion for the quarter, compared to analyst estimates of $25.52 billion. During the same period in the prior year, the business posted $1.57 earnings per share. The firm’s revenue for the quarter was up .5% compared to the same quarter last year.
ESRX has been the topic of several recent research reports. BidaskClub cut shares of Express Scripts Holding from a “hold” rating to a “sell” rating in a research note on Wednesday, July 12th. Needham & Company LLC initiated coverage on shares of Express Scripts Holding in a research note on Friday, July 21st. They issued a “hold” rating on the stock. Morgan Stanley lifted their price objective on shares of Express Scripts Holding from $52.00 to $57.00 and gave the stock an “underweight” rating in a research note on Thursday, August 10th. Jefferies Group LLC set a $72.00 price objective on shares of Express Scripts Holding and gave the stock a “buy” rating in a research note on Tuesday, August 29th. Finally, Robert W. Baird reaffirmed a “hold” rating and issued a $56.00 price objective on shares of Express Scripts Holding in a research note on Friday, September 1st. Six investment analysts have rated the stock with a sell rating, eleven have given a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $69.09.
In other news, VP Phyllis S. Anderson sold 578 shares of Express Scripts Holding stock in a transaction dated Friday, September 8th. The stock was sold at an average price of $63.13, for a total transaction of $36,489.14. Following the sale, the vice president now directly owns 10,530 shares of the company’s stock, valued at $664,758.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Woodrow A. Myers, Jr. sold 3,900 shares of Express Scripts Holding stock in a transaction dated Monday, September 11th. The shares were sold at an average price of $63.93, for a total value of $249,327.00. Following the sale, the director now directly owns 11,500 shares in the company, valued at $735,195. The disclosure for this sale can be found here. Insiders sold 5,641 shares of company stock worth $357,317 over the last ninety days. 0.68% of the stock is currently owned by insiders.
Several hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. boosted its stake in shares of Express Scripts Holding by 1.6% during the first quarter. Vanguard Group Inc. now owns 40,251,311 shares of the company’s stock valued at $2,652,964,000 after purchasing an additional 649,400 shares in the last quarter. Dodge & Cox lifted its stake in shares of Express Scripts Holding by 25.7% in the second quarter. Dodge & Cox now owns 36,188,517 shares of the company’s stock worth $2,310,275,000 after acquiring an additional 7,388,021 shares during the period. State Street Corp lifted its stake in shares of Express Scripts Holding by 1.1% in the first quarter. State Street Corp now owns 27,060,709 shares of the company’s stock worth $1,783,569,000 after acquiring an additional 298,341 shares during the period. Barrow Hanley Mewhinney & Strauss LLC lifted its stake in shares of Express Scripts Holding by 4.2% in the first quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 17,612,834 shares of the company’s stock worth $1,160,862,000 after acquiring an additional 704,218 shares during the period. Finally, Macquarie Group Ltd. lifted its stake in shares of Express Scripts Holding by 8.4% in the second quarter. Macquarie Group Ltd. now owns 11,880,919 shares of the company’s stock worth $758,480,000 after acquiring an additional 922,406 shares during the period. 88.69% of the stock is currently owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY NOTICE: “$25.61 Billion in Sales Expected for Express Scripts Holding Company (ESRX) This Quarter” was first published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece of content on another site, it was copied illegally and reposted in violation of US and international copyright and trademark law. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/10/23/25-61-billion-in-sales-expected-for-express-scripts-holding-company-esrx-this-quarter.html.
Shares of Express Scripts Holding (NASDAQ ESRX) traded down 1.11% on Monday, reaching $58.85. 690,871 shares of the company’s stock traded hands. Express Scripts Holding has a 52 week low of $55.80 and a 52 week high of $77.50. The company has a 50 day moving average price of $61.36 and a 200 day moving average price of $62.17. The firm has a market capitalization of $33.99 billion, a price-to-earnings ratio of 10.21 and a beta of 0.88.
About Express Scripts Holding
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.